There are more than 250 biologic medicines and vaccines that benefit millions of patients worldwide. In addition, there are more than 1,200 biotech diagnostic tests being used in clinics around the world. More than 600 new biologic medicines are in development, including treatments for cancer, HIV/AIDS, Alzheimerís disease, and numerous rare conditions.
Infectious diseases are the second leading cause of death worldwide, and new infectious diseases continue to emerge. Infants and children are among the most susceptible.
Fortunately, biotech is improving the odds for millions of patients around the world with life-threatening conditions and helping to combat everyday threats confronting the developing world.
WHO: BIO | BIO Suggests Update to WHO's Naming Policy for Biological Products
BIO presentes its recommendations to the World Health Organization (WHO) to assign a distinct nonproprietary name to each unique biological product, including follow-on biologics ("biosimilars").
Read the news release
Clinical Trials: Review of the Declaration of Helsinki
BIOís comments on the World Medical Associationís (WMAís) Declaration of Helsinki.
Read BIOís comments (56 KB PDF)
Clinical Trials: ICTRP guidelines
BIO urges the ICTRP to focus on developing a procedure that would address the need to balance the incentive to innovate with the need to provide patients and health care providers with the information they need in order to assess the availability and suitability of a clinical trial.
Read the letter (116 KB PDF)